6-cycle Carton (Carton 6cycle Deblitane)
Deblitane is a brand of Norethindrone Tablets, USP with a strength of 0.35mg.*
Deblitane Kit
Product Images NDC 16714-440
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deblitane (NDC 16714-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Figure 1 Nd Qd)
The text describes a figure labeled as Figure 1 that shows the mean and standard deviation of norethindrone plasma concentrations after its administration in tablet form.*
Norethindrone Structure (Norethindrone)
Norethindrone is a medication used as a form of hormonal birth control. It is a type of progestin, which is a synthetic form of the hormone progesterone. It works by preventing ovulation, thickening the cervical mucus to prevent sperm from reaching the uterus, and thinning the uterine lining to reduce the likelihood of implantation of a fertilized egg. It may also be used to treat menstrual disorders, endometriosis, or other conditions as prescribed by a healthcare provider.*
Table 1 (Table 1 Nd Qd)
This is a table showing pharmacokinetic parameters of norethindrone tablets administered as a single dose in 12 healthy female subjects under fasting conditions. The table displays the mean and standard deviation for the following parameters: time to maximum plasma concentration (Tmax), maximum plasma concentration (Cmax), and area under the plasma concentration-time curve from 0 to 48 hours (AUC(0-48)). The values in the table are in units of hours, pg/mL, and pg•hr/mL, respectively. The norethindrone tablet dosage is 0.35 mg. There is no useful information conveyed in "7.7x05", which appears to be a misread value.*
Table 2 (Table 2 Nd Qd)
This text is a table displaying the percentage of women experiencing unintended pregnancy during the first year of typical and perfect use for various methods of contraception, as well as the percentage of women continuing to use the method at the end of the first year in the United States. The table includes various methods of contraception, such as spermicides, diaphragms, male and female condoms, birth control pills, and other methods. The table also includes emergency contraceptive pills and lactational amenorrhea method. The source of data is a publication from 1998.*
Table Iud (Table Iud Nd Qd)
The text provides information on the effectiveness of various birth control methods including Depo-Provera, Norplant, condoms, diaphragms with spermicides, spermicides alone, cervical caps, and periodic abstinence. It also includes the percentage of women who rely on no birth control method.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
